Coya Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:COYA) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities -5.46 M-2.41 M-2.83 M-5.77 M-1.13 M -12.14 M Cash from investing activities 00-25 K00 — Cash from financing activities -56.33 K9.69 M19.14 K019.14 K 9.73 M Free cash flow -5.46 M-2.41 M-2.83 M-5.77 M-1.13 M -12.14 M

Nouvelles

H.C. Wainwright подтверждает рейтинг "Покупать" для акций Coya

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target

Coya Therapeutics привлекает $11,1 млн через частное размещение

Coya Therapeutics secures $11.1 million in private placement

Coya Therapeutics advances ALS and FTD clinical trials in 2026

H.C. Wainwright подтверждает рейтинг "Покупать" для акций Coya Therapeutics

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18

Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)

H.C. Wainwright подтверждает рейтинг "покупать" для акций Coya Therapeutics

H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock

H.C. Wainwright подтверждает рейтинг "Покупать" для акций Coya Therapeutics

H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target